{"log_id": 2624012964811037536, "direction": 0, "words_result_num": 223, "words_result": [{"probability": {"variance": 0.000151, "average": 0.994525, "min": 0.956059}, "location": {"width": 230, "top": 12, "height": 21, "left": 242}, "words": "弥散性结核和肺外表现。结核病的"}, {"probability": {"variance": 0.000859, "average": 0.985644, "min": 0.89894}, "location": {"width": 310, "top": 12, "height": 23, "left": 545}, "words": "在免疫抑制或者慢性感染患者中联合治疗"}, {"probability": {"variance": 6.5e-05, "average": 0.99621, "min": 0.964798}, "location": {"width": 360, "top": 34, "height": 21, "left": 244}, "words": "出现可能是由于潜伏性结核感染的本品的安全性"}, {"probability": {"variance": 0.000139, "average": 0.977007, "min": 0.965197}, "location": {"width": 30, "top": 36, "height": 17, "left": 687}, "words": "明确"}, {"probability": {"variance": 0.014274, "average": 0.953638, "min": 0.545309}, "location": {"width": 195, "top": 40, "height": 20, "left": 824}, "words": "在类风湿关节炎患者中进行为"}, {"probability": {"variance": 0.001101, "average": 0.985002, "min": 0.903846}, "location": {"width": 108, "top": 56, "height": 21, "left": 244}, "words": "复发或新的感染"}, {"probability": {"variance": 0.004926, "average": 0.984213, "min": 0.620624}, "location": {"width": 506, "top": 59, "height": 22, "left": 513}, "words": "恶性肿瘤和淋巴组织增殖性疾病2年的对照临床试验表明:本品"}, {"probability": {"variance": 0.000178, "average": 0.995513, "min": 0.949475}, "location": {"width": 201, "top": 76, "height": 21, "left": 273}, "words": "在开始使用本品治疗前,必须"}, {"probability": {"variance": 0.003778, "average": 0.984437, "min": 0.663351}, "location": {"width": 503, "top": 81, "height": 20, "left": 514}, "words": "实体瘤和恶性血液病(不包括皮与甲氨蝶呤联合使用不会导致非预"}, {"probability": {"variance": 2.7e-05, "average": 0.996227, "min": 0.981708}, "location": {"width": 305, "top": 97, "height": 24, "left": 243}, "words": "对结核病风险高的患者进行活动性肤癌"}, {"probability": {"variance": 1.2e-05, "average": 0.997398, "min": 0.986278}, "location": {"width": 223, "top": 104, "height": 18, "left": 796}, "words": "月的安全性事件,且本品与甲氨蝶"}, {"probability": {"variance": 0.00075, "average": 0.988053, "min": 0.90246}, "location": {"width": 233, "top": 119, "height": 19, "left": 242}, "words": "或潜伏性结核感染的评估。该评估"}, {"probability": {"variance": 0.008351, "average": 0.972958, "min": 0.507689}, "location": {"width": 473, "top": 124, "height": 23, "left": 545}, "words": "上市后曾有侵犯不同部位的恶呤联合使用的安全性特点与本品或"}, {"probability": {"variance": 0.000391, "average": 0.992557, "min": 0.921433}, "location": {"width": 232, "top": 139, "height": 19, "left": 243}, "words": "包括结核病患者的个人信息及详细"}, {"probability": {"variance": 2.8e-05, "average": 0.997728, "min": 0.978568}, "location": {"width": 233, "top": 160, "height": 17, "left": 243}, "words": "医疗史、以往与结核病人的接触史"}, {"probability": {"variance": 0.003138, "average": 0.978941, "min": 0.78156}, "location": {"width": 233, "top": 146, "height": 22, "left": 512}, "words": "性肿瘤的报告(参见“不良反应)"}, {"probability": {"variance": 0.014736, "average": 0.946722, "min": 0.592952}, "location": {"width": 215, "top": 145, "height": 19, "left": 803}, "words": "氨蝶呤单独使用时报告的安全性"}, {"probability": {"variance": 1.4e-05, "average": 0.997877, "min": 0.986566}, "location": {"width": 218, "top": 180, "height": 19, "left": 241}, "words": "和以往或目前的免疫抑制治疗法"}, {"probability": {"variance": 0.00836, "average": 0.955828, "min": 0.675306}, "location": {"width": 177, "top": 157, "height": 34, "left": 557}, "words": "TNF抑制剂的临床试验中"}, {"probability": {"variance": 0.000135, "average": 0.993836, "min": 0.959904}, "location": {"width": 231, "top": 165, "height": 19, "left": 786}, "words": "特点相似。目前正在进行长期联合"}, {"probability": {"variance": 0.000995, "average": 0.981785, "min": 0.850438}, "location": {"width": 505, "top": 187, "height": 22, "left": 513}, "words": "与对照组相比TNF抑制剂治疗患者用药安全性特点的评估。本品与其"}, {"probability": {"variance": 0.000429, "average": 0.990341, "min": 0.929546}, "location": {"width": 213, "top": 202, "height": 18, "left": 244}, "words": "所有患者需进行恰当的筛选试验"}, {"probability": {"variance": 0.000578, "average": 0.991921, "min": 0.878093}, "location": {"width": 443, "top": 207, "height": 21, "left": 513}, "words": "出现淋巴瘤的病例较多,但较为他改善病情的抗风湿药物"}, {"probability": {"variance": 0.007441, "average": 0.963767, "min": 0.665644}, "location": {"width": 230, "top": 221, "height": 20, "left": 242}, "words": "例郊结合菌素皮肤试验及胸部X线检"}, {"probability": {"variance": 0.000681, "average": 0.984742, "min": 0.89708}, "location": {"width": 507, "top": 229, "height": 20, "left": 512}, "words": "见,且安慰剂治疗患者的随访期比 DMARD)共同使用时,恩利的长"}, {"probability": {"variance": 0.001363, "average": 0.985556, "min": 0.845708}, "location": {"width": 229, "top": 242, "height": 20, "left": 241}, "words": "查(可以参考当地推荐的方法)。处"}, {"probability": {"variance": 0.000358, "average": 0.992641, "min": 0.92228}, "location": {"width": 219, "top": 249, "height": 23, "left": 511}, "words": "TNF抑制剂治疗患者的随访期短"}, {"probability": {"variance": 0, "average": 0.999436, "min": 0.998206}, "location": {"width": 127, "top": 249, "height": 18, "left": 785}, "words": "期安全性还未确定"}, {"probability": {"variance": 9e-06, "average": 0.997978, "min": 0.99013}, "location": {"width": 224, "top": 264, "height": 18, "left": 253}, "words": "医生应注意结核菌素皮肤试验出现"}, {"probability": {"variance": 0.000453, "average": 0.990866, "min": 0.915968}, "location": {"width": 219, "top": 272, "height": 19, "left": 530}, "words": "市后观察,使用TNF-抑制剂的"}, {"probability": {"variance": 5.3e-05, "average": 0.995729, "min": 0.97114}, "location": {"width": 205, "top": 270, "height": 20, "left": 819}, "words": "尚未进行本品与银屑病的其他系"}, {"probability": {"variance": 3.7e-05, "average": 0.995798, "min": 0.983787}, "location": {"width": 128, "top": 284, "height": 18, "left": 242}, "words": "假阴性的结果,特别"}, {"probability": {"variance": 1e-06, "average": 0.998879, "min": 0.997895}, "location": {"width": 38, "top": 285, "height": 16, "left": 413}, "words": "患有"}, {"probability": {"variance": 0.000596, "average": 0.990714, "min": 0.921681}, "location": {"width": 137, "top": 304, "height": 18, "left": 250}, "words": "病或免疫缺陷的患者"}, {"probability": {"variance": 0.015384, "average": 0.960575, "min": 0.468913}, "location": {"width": 463, "top": 290, "height": 24, "left": 531}, "words": "者有患白血病的报告,此外,长统疗法或光疗法共同使用的研究"}, {"probability": {"variance": 1.7e-05, "average": 0.998314, "min": 0.984645}, "location": {"width": 205, "top": 325, "height": 19, "left": 272}, "words": "如果患者确诊为活动性结核感"}, {"probability": {"variance": 0.005827, "average": 0.979179, "min": 0.633125}, "location": {"width": 385, "top": 314, "height": 20, "left": 516}, "words": "期处于高活性炎症疾病状态的类风肾和肝功能损害"}, {"probability": {"variance": 2.3e-05, "average": 0.997233, "min": 0.980796}, "location": {"width": 234, "top": 346, "height": 19, "left": 239}, "words": "染,则禁止使用本品治疗。在本品"}, {"probability": {"variance": 0.000108, "average": 0.994295, "min": 0.960416}, "location": {"width": 212, "top": 335, "height": 19, "left": 518}, "words": "显关节炎患者的淋巴瘤风险增加"}, {"probability": {"variance": 0.001439, "average": 0.9859, "min": 0.851917}, "location": {"width": 200, "top": 340, "height": 21, "left": 819}, "words": "根据药代动力学资料(参见“药"}, {"probability": {"variance": 0.000137, "average": 0.995698, "min": 0.952688}, "location": {"width": 231, "top": 367, "height": 18, "left": 240}, "words": "开始治疗前,必须预防潜伏性结核"}, {"probability": {"variance": 9e-06, "average": 0.998092, "min": 0.989395}, "location": {"width": 172, "top": 355, "height": 21, "left": 512}, "words": "从而使风险评估更为复杂"}, {"probability": {"variance": 0.002814, "average": 0.978815, "min": 0.78911}, "location": {"width": 228, "top": 362, "height": 19, "left": 790}, "words": "代动力学”),肝或肾功能损害患者"}, {"probability": {"variance": 0.010265, "average": 0.952987, "min": 0.691363}, "location": {"width": 230, "top": 387, "height": 20, "left": 241}, "words": "感染。有些治疗前潜伏性结核感菜"}, {"probability": {"variance": 0.046831, "average": 0.901304, "min": 0.382723}, "location": {"width": 196, "top": 376, "height": 20, "left": 544}, "words": "就舀前所知情况,不能排"}, {"probability": {"variance": 0.00022, "average": 0.993754, "min": 0.94544}, "location": {"width": 233, "top": 381, "height": 21, "left": 785}, "words": "无需进行剂量调整;针对这些患者"}, {"probability": {"variance": 0.021891, "average": 0.957201, "min": 0.404098}, "location": {"width": 232, "top": 407, "height": 20, "left": 243}, "words": "测为阴性的患者,使用本品后发"}, {"probability": {"variance": 0.00012, "average": 0.995436, "min": 0.958008}, "location": {"width": 202, "top": 395, "height": 21, "left": 541}, "words": "抑制剂治疗患者出现淋巴瘤或"}, {"probability": {"variance": 0, "average": 0.999342, "min": 0.998044}, "location": {"width": 109, "top": 401, "height": 21, "left": 785}, "words": "的临床经验有限"}, {"probability": {"variance": 0.008749, "average": 0.972289, "min": 0.623168}, "location": {"width": 236, "top": 427, "height": 22, "left": 239}, "words": "展为活动性结核感染。使用本品过"}, {"probability": {"variance": 1.8e-05, "average": 0.997757, "min": 0.985497}, "location": {"width": 153, "top": 418, "height": 19, "left": 591}, "words": "瘤的风险。对于有恶性"}, {"probability": {"variance": 0.000111, "average": 0.994243, "min": 0.958376}, "location": {"width": 232, "top": 438, "height": 19, "left": 512}, "words": "肿瘤病史或发生恶性肿瘤但考虑继"}, {"probability": {"variance": 2.3e-05, "average": 0.996914, "min": 0.985999}, "location": {"width": 116, "top": 427, "height": 19, "left": 785}, "words": "充血性心力衰竭"}, {"probability": {"variance": 2e-06, "average": 0.999031, "min": 0.99406}, "location": {"width": 233, "top": 448, "height": 20, "left": 240}, "words": "程中医生应监测患者有活动性结核"}, {"probability": {"variance": 8.1e-05, "average": 0.992975, "min": 0.968791}, "location": {"width": 200, "top": 452, "height": 19, "left": 819}, "words": "充血性心力衰竭(CHF)患者使"}, {"probability": {"variance": 0.001446, "average": 0.986148, "min": 0.850757}, "location": {"width": 232, "top": 469, "height": 20, "left": 240}, "words": "感染的体征和症状,包括那些潜伏"}, {"probability": {"variance": 3e-06, "average": 0.9984, "min": 0.994862}, "location": {"width": 218, "top": 458, "height": 19, "left": 512}, "words": "续治疗的患者,在考虑其使用T"}, {"probability": {"variance": 2e-06, "average": 0.9988, "min": 0.995112}, "location": {"width": 168, "top": 477, "height": 19, "left": 513}, "words": "抑制剂治疗时应警惕使用"}, {"probability": {"variance": 0.003728, "average": 0.978359, "min": 0.752261}, "location": {"width": 223, "top": 474, "height": 17, "left": 796}, "words": "本品时,医师应特别谨慎。上市后"}, {"probability": {"variance": 0.000154, "average": 0.993726, "min": 0.951765}, "location": {"width": 229, "top": 489, "height": 20, "left": 242}, "words": "性感染检测阴性的患者。并应参考"}, {"probability": {"variance": 5.9e-05, "average": 0.997058, "min": 0.972879}, "location": {"width": 184, "top": 498, "height": 20, "left": 541}, "words": "在上市后观察,在使用T"}, {"probability": {"variance": 1e-06, "average": 0.998491, "min": 0.997373}, "location": {"width": 27, "top": 494, "height": 18, "left": 786}, "words": "曾有"}, {"probability": {"variance": 1.1e-05, "average": 0.9978, "min": 0.992159}, "location": {"width": 66, "top": 495, "height": 15, "left": 868}, "words": "的患者在"}, {"probability": {"variance": 8.3e-05, "average": 0.990412, "min": 0.981303}, "location": {"width": 24, "top": 495, "height": 17, "left": 994}, "words": "显促"}, {"probability": {"variance": 0.000449, "average": 0.992687, "min": 0.91393}, "location": {"width": 232, "top": 511, "height": 18, "left": 239}, "words": "适用的当地治疗指南。如果患者确"}, {"probability": {"variance": 5e-06, "average": 0.998478, "min": 0.992094}, "location": {"width": 174, "top": 512, "height": 20, "left": 786}, "words": "发因素的情况下出现充血性"}, {"probability": {"variance": 0.001412, "average": 0.988819, "min": 0.84838}, "location": {"width": 228, "top": 531, "height": 17, "left": 243}, "words": "诊为潜伏性结核病,则在开始使用"}, {"probability": {"variance": 6.6e-05, "average": 0.993328, "min": 0.973245}, "location": {"width": 222, "top": 518, "height": 21, "left": 516}, "words": "印制剂(包括本品)治疗的儿童"}, {"probability": {"variance": 0.002977, "average": 0.98086, "min": 0.705673}, "location": {"width": 472, "top": 532, "height": 26, "left": 516}, "words": "青少年和成年(大于22岁)患者加的报告。两项用于评价本品"}, {"probability": {"variance": 1.2e-05, "average": 0.997947, "min": 0.98616}, "location": {"width": 233, "top": 551, "height": 19, "left": 238}, "words": "本品前必须按照当地推荐的方法进"}, {"probability": {"variance": 9.1e-05, "average": 0.994526, "min": 0.960948}, "location": {"width": 228, "top": 560, "height": 19, "left": 517}, "words": "中有致命恶性肿瘤(特别是何杰金"}, {"probability": {"variance": 0.000712, "average": 0.989427, "min": 0.898826}, "location": {"width": 232, "top": 554, "height": 19, "left": 786}, "words": "充血性心力衰竭患者的大规模临床试"}, {"probability": {"variance": 0.028022, "average": 0.939599, "min": 0.356816}, "location": {"width": 224, "top": 573, "height": 18, "left": 248}, "words": "抗结核治疗。在这种情况下,应"}, {"probability": {"variance": 0.000113, "average": 0.995178, "min": 0.956938}, "location": {"width": 232, "top": 592, "height": 19, "left": 239}, "words": "慎重考虑使用本品治疗的受益/风"}, {"probability": {"variance": 3.5e-05, "average": 0.995698, "min": 0.980753}, "location": {"width": 230, "top": 581, "height": 19, "left": 515}, "words": "无和非何杰金氏淋巴瘤)的报告起"}, {"probability": {"variance": 6.4e-05, "average": 0.995767, "min": 0.967114}, "location": {"width": 234, "top": 575, "height": 20, "left": 785}, "words": "验因缺乏疗效而终止。尽管不是最终"}, {"probability": {"variance": 0.01809, "average": 0.931586, "min": 0.494581}, "location": {"width": 226, "top": 600, "height": 20, "left": 512}, "words": "始治疗不大于18岁)。大概半数的"}, {"probability": {"variance": 9.5e-05, "average": 0.992853, "min": 0.970155}, "location": {"width": 230, "top": 595, "height": 20, "left": 789}, "words": "结论,但其中一项试验的资料显示使"}, {"probability": {"variance": 0.000152, "average": 0.995409, "min": 0.950383}, "location": {"width": 232, "top": 613, "height": 19, "left": 239}, "words": "险平衡。类风湿关节炎患者结核感"}, {"probability": {"variance": 0.011821, "average": 0.959513, "min": 0.589566}, "location": {"width": 235, "top": 622, "height": 19, "left": 509}, "words": "报告是淋巴瘤。此外还包括其他各"}, {"probability": {"variance": 9.8e-05, "average": 0.994372, "min": 0.964645}, "location": {"width": 232, "top": 616, "height": 19, "left": 785}, "words": "用本品治疗的患者可能存在加重充血"}, {"probability": {"variance": 1e-06, "average": 0.998775, "min": 0.996736}, "location": {"width": 109, "top": 632, "height": 19, "left": 239}, "words": "染的几率会更高"}, {"probability": {"variance": 0.000507, "average": 0.992919, "min": 0.908842}, "location": {"width": 229, "top": 643, "height": 17, "left": 510}, "words": "种恶性肿瘤以及典型的与免疫抑制"}, {"probability": {"variance": 1.9e-05, "average": 0.996243, "min": 0.987936}, "location": {"width": 106, "top": 637, "height": 18, "left": 786}, "words": "性心力衰竭的倾"}, {"probability": {"variance": 5e-06, "average": 0.998146, "min": 0.992124}, "location": {"width": 202, "top": 654, "height": 20, "left": 270}, "words": "应告知患者在使用本品治疗期"}, {"probability": {"variance": 0.000508, "average": 0.992007, "min": 0.922616}, "location": {"width": 355, "top": 661, "height": 20, "left": 513}, "words": "相关的罕见的恶性肿瘤。不能除外酒精性肝炎"}, {"probability": {"variance": 6.3e-05, "average": 0.996727, "min": 0.967425}, "location": {"width": 232, "top": 674, "height": 19, "left": 238}, "words": "间或治疗以后,患者若出现结核病"}, {"probability": {"variance": 5.3e-05, "average": 0.996184, "min": 0.971596}, "location": {"width": 230, "top": 693, "height": 22, "left": 244}, "words": "例如,持续性咳嗽、体重减轻和"}, {"probability": {"variance": 0.002027, "average": 0.985375, "min": 0.811775}, "location": {"width": 232, "top": 681, "height": 22, "left": 511}, "words": "儿童和青少年使用TNF-抑制剂治"}, {"probability": {"variance": 0.0001, "average": 0.993953, "min": 0.965668}, "location": {"width": 200, "top": 686, "height": 19, "left": 818}, "words": "在一项期随机安慰剂对照的"}, {"probability": {"variance": 0.011479, "average": 0.959109, "min": 0.585395}, "location": {"width": 229, "top": 714, "height": 21, "left": 242}, "words": "氏热)的体征/症状均应寻求医学"}, {"probability": {"variance": 0, "average": 0.999461, "min": 0.998646}, "location": {"width": 145, "top": 704, "height": 19, "left": 510}, "words": "疗发生恶性肿瘤的风"}, {"probability": {"variance": 9e-06, "average": 0.997829, "min": 0.990528}, "location": {"width": 234, "top": 705, "height": 20, "left": 784}, "words": "研究中,对48例患有中度或重度酒"}, {"probability": {"variance": 1e-06, "average": 0.998667, "min": 0.997534}, "location": {"width": 29, "top": 735, "height": 18, "left": 240}, "words": "指导"}, {"probability": {"variance": 0.000884, "average": 0.965854, "min": 0.926094}, "location": {"width": 43, "top": 728, "height": 19, "left": 516}, "words": "皮肤癌"}, {"probability": {"variance": 4.3e-05, "average": 0.995561, "min": 0.9802}, "location": {"width": 232, "top": 727, "height": 19, "left": 785}, "words": "精性肝炎的住院病人进行本品或安"}, {"probability": {"variance": 0.000943, "average": 0.985428, "min": 0.906151}, "location": {"width": 133, "top": 759, "height": 20, "left": 238}, "words": "乙型肝炎病毒激活"}, {"probability": {"variance": 0.015335, "average": 0.949543, "min": 0.512521}, "location": {"width": 197, "top": 753, "height": 20, "left": 543}, "words": "普报告采用TNF-抑制剂(包"}, {"probability": {"variance": 0.000596, "average": 0.988534, "min": 0.90631}, "location": {"width": 225, "top": 748, "height": 19, "left": 786}, "words": "慰剂治疗。结果显示,本品治疗无效"}, {"probability": {"variance": 1.2e-05, "average": 0.998683, "min": 0.986753}, "location": {"width": 198, "top": 783, "height": 19, "left": 270}, "words": "曾有慢性乙型肝炎病毒的携带"}, {"probability": {"variance": 0.001457, "average": 0.981359, "min": 0.824338}, "location": {"width": 507, "top": 768, "height": 24, "left": 510}, "words": "括本品)治疗的患者产生黑色素瘤并且治疗6个月后,本品用药组的"}, {"probability": {"variance": 0.022056, "average": 0.951392, "min": 0.385138}, "location": {"width": 223, "top": 803, "height": 20, "left": 244}, "words": "接受包括本品在内的TNF抑制齐"}, {"probability": {"variance": 0.000262, "average": 0.994184, "min": 0.940698}, "location": {"width": 184, "top": 793, "height": 19, "left": 511}, "words": "皮肤癌和非黑色素瘤皮肤瘙"}, {"probability": {"variance": 0.000935, "average": 0.987471, "min": 0.877771}, "location": {"width": 232, "top": 789, "height": 18, "left": 785}, "words": "死亡率明显较高。所以,不推荐酒"}, {"probability": {"variance": 0.000314, "average": 0.986689, "min": 0.954463}, "location": {"width": 135, "top": 826, "height": 16, "left": 238}, "words": "治疗时出现乙肝病毒"}, {"probability": {"variance": 0.005252, "average": 0.959566, "min": 0.714943}, "location": {"width": 228, "top": 814, "height": 20, "left": 516}, "words": "NMSC)。本品治疗患者中十分罕"}, {"probability": {"variance": 3e-05, "average": 0.99675, "min": 0.977197}, "location": {"width": 232, "top": 809, "height": 19, "left": 785}, "words": "精性肝炎病人使用本品治疗。对于"}, {"probability": {"variance": 5e-05, "average": 0.995208, "min": 0.97828}, "location": {"width": 214, "top": 835, "height": 19, "left": 509}, "words": "见 Merkel细胞癌的上市后报告"}, {"probability": {"variance": 1.2e-05, "average": 0.998511, "min": 0.985749}, "location": {"width": 232, "top": 829, "height": 18, "left": 785}, "words": "患有中度或重度酒精性肝炎的患者"}, {"probability": {"variance": 0.000795, "average": 0.987588, "min": 0.88634}, "location": {"width": 233, "top": 845, "height": 19, "left": 238}, "words": "的报告。有HBV感染风险的患者"}, {"probability": {"variance": 4e-06, "average": 0.99867, "min": 0.991863}, "location": {"width": 227, "top": 849, "height": 21, "left": 785}, "words": "使用本品治疗时,医生应谨慎使用"}, {"probability": {"variance": 3.4e-05, "average": 0.996536, "min": 0.986444}, "location": {"width": 59, "top": 866, "height": 17, "left": 238}, "words": "在开始抗"}, {"probability": {"variance": 0, "average": 0.999492, "min": 0.998688}, "location": {"width": 131, "top": 867, "height": 17, "left": 343}, "words": "治疗前,必须对先"}, {"probability": {"variance": 6.3e-05, "average": 0.995774, "min": 0.970463}, "location": {"width": 231, "top": 855, "height": 20, "left": 512}, "words": "推荐所有患皮肤癌风险增高的患者"}, {"probability": {"variance": 2e-06, "average": 0.998849, "min": 0.996007}, "location": {"width": 156, "top": 876, "height": 17, "left": 510}, "words": "进行周期性的皮肤检查"}, {"probability": {"variance": 0.021538, "average": 0.954109, "min": 0.467418}, "location": {"width": 179, "top": 886, "height": 19, "left": 237}, "words": "前HBⅤ感染情况进行评价"}, {"probability": {"variance": 2.3e-05, "average": 0.995457, "min": 0.986743}, "location": {"width": 129, "top": 873, "height": 21, "left": 784}, "words": " Wegener氏肉芽肿"}, {"probability": {"variance": 0.00755, "average": 0.972016, "min": 0.671194}, "location": {"width": 203, "top": 905, "height": 20, "left": 268}, "words": "尚不明确本品和HBV激活的"}, {"probability": {"variance": 7e-06, "average": 0.997682, "min": 0.992598}, "location": {"width": 204, "top": 895, "height": 20, "left": 540}, "words": "在本品的临床试验中综合对照"}, {"probability": {"variance": 1.3e-05, "average": 0.997855, "min": 0.989001}, "location": {"width": 202, "top": 898, "height": 21, "left": 814}, "words": "在一项平均持续时间为25个"}, {"probability": {"variance": 0.028576, "average": 0.923078, "min": 0.400137}, "location": {"width": 233, "top": 925, "height": 20, "left": 238}, "words": "因果关系,已磅诊为HB携带者"}, {"probability": {"variance": 3.1e-05, "average": 0.997199, "min": 0.981817}, "location": {"width": 235, "top": 915, "height": 22, "left": 509}, "words": "部分的结果发现,与对照组相比本"}, {"probability": {"variance": 0.000457, "average": 0.988842, "min": 0.933259}, "location": {"width": 229, "top": 917, "height": 21, "left": 784}, "words": "月安慰剂对照试验中,89名成年"}, {"probability": {"variance": 2e-06, "average": 0.998646, "min": 0.994608}, "location": {"width": 229, "top": 947, "height": 21, "left": 236}, "words": "的患者使用本品时,应谨慎使用"}, {"probability": {"variance": 0.009416, "average": 0.967853, "min": 0.50497}, "location": {"width": 489, "top": 937, "height": 22, "left": 509}, "words": "品治疗组患者产生NMSC的病例患者接受本品和标准疗法(包括"}, {"probability": {"variance": 0.021456, "average": 0.957944, "min": 0.42984}, "location": {"width": 227, "top": 967, "height": 20, "left": 236}, "words": "如果HB携带者使用本品治疗"}, {"probability": {"variance": 1e-05, "average": 0.998167, "min": 0.988488}, "location": {"width": 171, "top": 959, "height": 16, "left": 510}, "words": "较多,尤其在银屑病患者"}, {"probability": {"variance": 0.006748, "average": 0.947129, "min": 0.726588}, "location": {"width": 220, "top": 960, "height": 19, "left": 784}, "words": "磷酰胺、甲氨蝶呤和糖皮质激素"}, {"probability": {"variance": 0.006261, "average": 0.97078, "min": 0.694896}, "location": {"width": 234, "top": 988, "height": 19, "left": 237}, "words": "应监测HBV感染激活的体征和症"}, {"probability": {"variance": 6e-06, "average": 0.997812, "min": 0.993469}, "location": {"width": 65, "top": 982, "height": 19, "left": 508}, "words": "疫苗接种"}, {"probability": {"variance": 0.000357, "average": 0.991476, "min": 0.934244}, "location": {"width": 233, "top": 980, "height": 19, "left": 784}, "words": "结果并未显示本品对 Wegener氏"}, {"probability": {"variance": 0.000827, "average": 0.990054, "min": 0.890821}, "location": {"width": 202, "top": 1009, "height": 19, "left": 237}, "words": "状,必要时应采取恰当的治疗"}, {"probability": {"variance": 8e-06, "average": 0.998249, "min": 0.991798}, "location": {"width": 203, "top": 1006, "height": 20, "left": 539}, "words": "本品治疗过程中严禁使用活疫"}, {"probability": {"variance": 0.00029, "average": 0.994083, "min": 0.930896}, "location": {"width": 229, "top": 1002, "height": 18, "left": 783}, "words": "肉芽肿的治疗有效。本品治疗组出"}, {"probability": {"variance": 0, "average": 0.999322, "min": 0.998445}, "location": {"width": 99, "top": 1032, "height": 20, "left": 236}, "words": "丙型肝炎恶化"}, {"probability": {"variance": 4.6e-05, "average": 0.996492, "min": 0.972839}, "location": {"width": 229, "top": 1027, "height": 19, "left": 509}, "words": "苗。尚无接受本品治疗的患者由于"}, {"probability": {"variance": 0.001041, "average": 0.98751, "min": 0.876433}, "location": {"width": 219, "top": 1022, "height": 19, "left": 784}, "words": "现各种类型非皮肤恶性肿瘤的发"}, {"probability": {"variance": 3e-06, "average": 0.99892, "min": 0.993375}, "location": {"width": 234, "top": 1048, "height": 20, "left": 509}, "words": "接受活疫苗而发生二次传播感染的"}, {"probability": {"variance": 0.000231, "average": 0.990853, "min": 0.9451}, "location": {"width": 235, "top": 1043, "height": 18, "left": 784}, "words": "率显著高于对照组。不推荐使用"}, {"probability": {"variance": 0.000228, "average": 0.992969, "min": 0.95093}, "location": {"width": 203, "top": 1057, "height": 19, "left": 268}, "words": "曾有使用本品治疗的患者出现丙"}, {"probability": {"variance": 0.010141, "average": 0.940652, "min": 0.710325}, "location": {"width": 169, "top": 1063, "height": 20, "left": 784}, "words": "品治疗 Wegener氏肉芽"}, {"probability": {"variance": 4.5e-05, "average": 0.996365, "min": 0.979364}, "location": {"width": 233, "top": 1076, "height": 20, "left": 238}, "words": "型肝炎恶化的报告,但是尚不明确本"}, {"probability": {"variance": 0.000592, "average": 0.981315, "min": 0.929591}, "location": {"width": 165, "top": 1068, "height": 18, "left": 573}, "words": "项双盲、安慰剂对照的随"}, {"probability": {"variance": 2.8e-05, "average": 0.996617, "min": 0.981027}, "location": {"width": 191, "top": 1098, "height": 17, "left": 238}, "words": "品和丙型肝炎恶化的因果关系"}, {"probability": {"variance": 0.013831, "average": 0.972118, "min": 0.3661}, "location": {"width": 483, "top": 1086, "height": 26, "left": 510}, "words": "机临床试验中,184例成年银屑病治疗糖尿病患者的低血糖"}, {"probability": {"variance": 3.4e-05, "average": 0.99726, "min": 0.980032}, "location": {"width": 162, "top": 1121, "height": 19, "left": 235}, "words": "糖尿病患者的低血糖症"}, {"probability": {"variance": 0.0001, "average": 0.996219, "min": 0.959294}, "location": {"width": 233, "top": 1108, "height": 21, "left": 510}, "words": "关节炎患者在第4周接受了多价肺"}, {"probability": {"variance": 5e-06, "average": 0.99816, "min": 0.994054}, "location": {"width": 107, "top": 1112, "height": 18, "left": 814}, "words": "有报告对于接受"}, {"probability": {"variance": 0.011706, "average": 0.972283, "min": 0.478248}, "location": {"width": 382, "top": 1128, "height": 21, "left": 510}, "words": "炎球菌多糖疫苗,多数接受本品治患者,开始使用"}, {"probability": {"variance": 5.6e-05, "average": 0.997025, "min": 0.961554}, "location": {"width": 482, "top": 1144, "height": 30, "left": 265}, "words": "曾有患者使用糖尿病治疗药物疗的银屑病性关节炎患者能对肺炎"}, {"probability": {"variance": 1e-06, "average": 0.998836, "min": 0.996975}, "location": {"width": 108, "top": 1151, "height": 19, "left": 783}, "words": "糖,需要对一些"}, {"probability": {"variance": 0, "average": 0.999508, "min": 0.997274}, "location": {"width": 233, "top": 1165, "height": 19, "left": 236}, "words": "后使用本品治疗出现低血糖症的报"}, {"probability": {"variance": 2.5e-05, "average": 0.997868, "min": 0.978936}, "location": {"width": 295, "top": 1170, "height": 20, "left": 507}, "words": "球菌多糖疫苗产生有效的B细胞免病"}, {"probability": {"variance": 0, "average": 0.984534, "min": 0.984534}, "location": {"width": 14, "top": 1175, "height": 16, "left": 862}, "words": "用"}, {"probability": {"variance": 2.3e-05, "average": 0.997069, "min": 0.983469}, "location": {"width": 233, "top": 1185, "height": 20, "left": 237}, "words": "告,其中一些患者不得不减少使用"}, {"probability": {"variance": 1e-06, "average": 0.999436, "min": 0.997799}, "location": {"width": 110, "top": 1207, "height": 18, "left": 236}, "words": "抗糖尿病的药物"}, {"probability": {"variance": 0.005067, "average": 0.960605, "min": 0.709263}, "location": {"width": 487, "top": 1200, "height": 33, "left": 511}, "words": "患者比较,总滴度略低,但少数患【孕妇及哺乳期妇女用药"}, {"probability": {"variance": 6e-06, "average": 0.997124, "min": 0.992866}, "location": {"width": 196, "top": 1230, "height": 21, "left": 235}, "words": "本品和阿那白滞素联合治疗"}, {"probability": {"variance": 1.3e-05, "average": 0.997304, "min": 0.989536}, "location": {"width": 234, "top": 1232, "height": 18, "left": 509}, "words": "者滴度增加2倍,但其临床意义尚"}, {"probability": {"variance": 0.000134, "average": 0.995402, "min": 0.960779}, "location": {"width": 146, "top": 1239, "height": 19, "left": 814}, "words": "没有开展妊娠妇女使用"}, {"probability": {"variance": 0.003843, "average": 0.973629, "min": 0.743393}, "location": {"width": 290, "top": 1254, "height": 20, "left": 266}, "words": "与单独使用本品相比,本品和不明确"}, {"probability": {"variance": 0.025106, "average": 0.92649, "min": 0.572223}, "location": {"width": 86, "top": 1259, "height": 18, "left": 783}, "words": "究,因此尚未"}, {"probability": {"variance": 1.6e-05, "average": 0.996101, "min": 0.988524}, "location": {"width": 74, "top": 1262, "height": 17, "left": 931}, "words": "妇女使用本"}, {"probability": {"variance": 5.2e-05, "average": 0.996264, "min": 0.968163}, "location": {"width": 377, "top": 1274, "height": 23, "left": 233}, "words": "阿那白滞素联合治疗与严重感染和自身抗体形成"}, {"probability": {"variance": 4e-06, "average": 0.998918, "min": 0.991429}, "location": {"width": 232, "top": 1278, "height": 21, "left": 784}, "words": "的安全性。在大鼠和家兔中进行的发"}, {"probability": {"variance": 2.4e-05, "average": 0.997754, "min": 0.980624}, "location": {"width": 232, "top": 1295, "height": 19, "left": 238}, "words": "中性粒细胞减少风险增高相关。并"}, {"probability": {"variance": 0.009744, "average": 0.948705, "min": 0.673014}, "location": {"width": 285, "top": 1300, "height": 21, "left": 545}, "words": "本品治疗可能会产生自身抗体育毒性"}, {"probability": {"variance": 0.002637, "average": 0.976885, "min": 0.835218}, "location": {"width": 132, "top": 1301, "height": 18, "left": 884}, "words": "发现本品对胎崽的损"}, {"probability": {"variance": 0.008018, "average": 0.973294, "min": 0.638682}, "location": {"width": 227, "top": 1317, "height": 23, "left": 237}, "words": "未证实这种联合疗法可以增加临床"}, {"probability": {"variance": 7e-06, "average": 0.998291, "min": 0.992}, "location": {"width": 111, "top": 1322, "height": 19, "left": 514}, "words": "参见“不良反应"}, {"probability": {"variance": 0.000142, "average": 0.989693, "min": 0.970844}, "location": {"width": 86, "top": 1321, "height": 17, "left": 783}, "words": "害。还没有关"}, {"probability": {"variance": 0.012733, "average": 0.934075, "min": 0.738631}, "location": {"width": 51, "top": 1322, "height": 17, "left": 965}, "words": "阴和产后"}, {"probability": {"variance": 2.4e-05, "average": 0.997048, "min": 0.983639}, "location": {"width": 135, "top": 1336, "height": 18, "left": 237}, "words": "效果。因此不推荐本"}, {"probability": {"variance": 0.016269, "average": 0.908391, "min": 0.690758}, "location": {"width": 64, "top": 1338, "height": 16, "left": 405}, "words": "阿那白滯"}, {"probability": {"variance": 0, "average": 0.999676, "min": 0.998887}, "location": {"width": 82, "top": 1346, "height": 18, "left": 509}, "words": "血液学反应"}, {"probability": {"variance": 0.000205, "average": 0.993871, "min": 0.944513}, "location": {"width": 230, "top": 1340, "height": 19, "left": 783}, "words": "毒性以及本品对生育力和生殖能力的"}, {"probability": {"variance": 1.1e-05, "average": 0.996656, "min": 0.989352}, "location": {"width": 234, "top": 1357, "height": 19, "left": 236}, "words": "素联合使用(参见“药物相互作用"}, {"probability": {"variance": 0.001352, "average": 0.984228, "min": 0.892618}, "location": {"width": 201, "top": 1370, "height": 20, "left": 539}, "words": "接受本品治疗的患者罕见报告出"}, {"probability": {"variance": 8e-06, "average": 0.998429, "min": 0.989777}, "location": {"width": 233, "top": 1360, "height": 20, "left": 784}, "words": "影响的临床前数据,且动物的生殖研"}, {"probability": {"variance": 5e-06, "average": 0.998394, "min": 0.99347}, "location": {"width": 96, "top": 1375, "height": 19, "left": 235}, "words": "和“不良反应"}, {"probability": {"variance": 6.8e-05, "average": 0.995556, "min": 0.971219}, "location": {"width": 183, "top": 1400, "height": 20, "left": 234}, "words": "本品和阿巴他塞联合治疗"}, {"probability": {"variance": 0, "average": 0.999678, "min": 0.999632}, "location": {"width": 27, "top": 1392, "height": 16, "left": 555}, "words": "细胞"}, {"probability": {"variance": 5e-06, "average": 0.99774, "min": 0.992122}, "location": {"width": 114, "top": 1392, "height": 16, "left": 630}, "words": "十分罕见报告出现"}, {"probability": {"variance": 5e-06, "average": 0.998291, "min": 0.99181}, "location": {"width": 219, "top": 1381, "height": 19, "left": 784}, "words": "究并不能很好预示在人体中的结果"}, {"probability": {"variance": 1e-06, "average": 0.999019, "min": 0.997006}, "location": {"width": 103, "top": 1412, "height": 16, "left": 508}, "words": "再生障碍性贫血"}, {"probability": {"variance": 4e-06, "average": 0.998621, "min": 0.994536}, "location": {"width": 85, "top": 1401, "height": 19, "left": 785}, "words": "因此,不推荐"}, {"probability": {"variance": 0.000334, "average": 0.986748, "min": 0.96091}, "location": {"width": 45, "top": 1413, "height": 17, "left": 698}, "words": "亡。有"}, {"probability": {"variance": 0.001353, "average": 0.969498, "min": 0.910113}, "location": {"width": 86, "top": 1402, "height": 19, "left": 932}, "words": "吏用本品,建"}, {"probability": {"variance": 0.009215, "average": 0.954644, "min": 0.614206}, "location": {"width": 473, "top": 1425, "height": 25, "left": 265}, "words": "在临研究中,本品和阿巴他塞血恶液质病史的患者使用本品治疗时"}, {"probability": {"variance": 0.016584, "average": 0.943929, "min": 0.500678}, "location": {"width": 229, "top": 1423, "height": 19, "left": 782}, "words": "议育站妇女在本品治疗期间不要怀孕"}, {"probability": {"variance": 0.006914, "average": 0.955452, "min": 0.771315}, "location": {"width": 79, "top": 1445, "height": 19, "left": 234}, "words": "联合治疗导到"}, {"probability": {"variance": 1e-06, "average": 0.99856, "min": 0.997601}, "location": {"width": 64, "top": 1446, "height": 17, "left": 379}, "words": "事件的发"}, {"probability": {"variance": 0.000201, "average": 0.993966, "min": 0.940714}, "location": {"width": 236, "top": 1452, "height": 20, "left": 507}, "words": "应谨慎使用。使用本品过程中,所有"}, {"probability": {"variance": 0.000673, "average": 0.986932, "min": 0.911035}, "location": {"width": 144, "top": 1443, "height": 19, "left": 784}, "words": "仅在当明确需要时,妊"}, {"probability": {"variance": 0, "average": 0.999901, "min": 0.999901}, "location": {"width": 16, "top": 1444, "height": 18, "left": 1001}, "words": "使"}, {"probability": {"variance": 0.008572, "average": 0.967869, "min": 0.552938}, "location": {"width": 500, "top": 1463, "height": 31, "left": 234}, "words": "增加,并未证实这种联合疗法可以增出现血恶液质或感染征兆(比如持线"}, {"probability": {"variance": 5e-06, "average": 0.998137, "min": 0.994131}, "location": {"width": 73, "top": 1463, "height": 18, "left": 783}, "words": "用本品治疗"}, {"probability": {"variance": 0.000204, "average": 0.994572, "min": 0.949539}, "location": {"width": 157, "top": 1487, "height": 18, "left": 237}, "words": "加临床效果,因此不推荐"}, {"probability": {"variance": 0.000466, "average": 0.985091, "min": 0.926603}, "location": {"width": 216, "top": 1493, "height": 19, "left": 514}, "words": "热、咽喉痛、淤血、出血、苍白"}, {"probability": {"variance": 0.007662, "average": 0.958459, "min": 0.762865}, "location": {"width": 99, "top": 1486, "height": 21, "left": 783}, "words": "哺乳期的使用"}, {"probability": {"variance": 2e-06, "average": 0.999025, "min": 0.996774}, "location": {"width": 67, "top": 1510, "height": 20, "left": 233}, "words": "变态反应"}, {"probability": {"variance": 0.001998, "average": 0.98583, "min": 0.814483}, "location": {"width": 236, "top": 1514, "height": 19, "left": 506}, "words": "的患者,应立即寻求医疗指导。以上"}, {"probability": {"variance": 0.005836, "average": 0.967842, "min": 0.730552}, "location": {"width": 183, "top": 1513, "height": 18, "left": 813}, "words": "尚未建立哺乳期妇女使用本"}, {"probability": {"variance": 0.005973, "average": 0.980318, "min": 0.486832}, "location": {"width": 750, "top": 1532, "height": 21, "left": 265}, "words": "常有报道与本品使用相关的变患者应当立即进行包括全租细胞计数的安全性。有报道本品皮下注射后"}, {"probability": {"variance": 0.001572, "average": 0.985478, "min": 0.815335}, "location": {"width": 774, "top": 1553, "height": 21, "left": 233}, "words": "态反应。变态反应包括血管性水肿在内的检查;如果确诊血恶液质,必可从人的乳汁中分泌。皮下注射"}, {"probability": {"variance": 0.000144, "average": 0.994358, "min": 0.943918}, "location": {"width": 379, "top": 1575, "height": 19, "left": 233}, "words": "和荨麻疹,严重的此类反应曾有发须停止使用本品"}, {"probability": {"variance": 2.8e-05, "average": 0.996695, "min": 0.978807}, "location": {"width": 227, "top": 1575, "height": 18, "left": 784}, "words": "予哺乳期大鼠后,本品可以通过乳汁"}, {"probability": {"variance": 0.001621, "average": 0.984274, "min": 0.852703}, "location": {"width": 206, "top": 1596, "height": 18, "left": 231}, "words": "生。如果出现任何重度的变态"}, {"probability": {"variance": 2e-06, "average": 0.999039, "min": 0.996557}, "location": {"width": 135, "top": 1599, "height": 20, "left": 505}, "words": "中枢神经系统疾病"}, {"probability": {"variance": 6e-06, "average": 0.99803, "min": 0.993949}, "location": {"width": 116, "top": 1595, "height": 18, "left": 782}, "words": "排泄,且可以在胎"}, {"probability": {"variance": 0.032797, "average": 0.9283, "min": 0.418562}, "location": {"width": 138, "top": 1617, "height": 17, "left": 235}, "words": "反应,必须立即停"}, {"probability": {"variance": 5.5e-05, "average": 0.991825, "min": 0.984417}, "location": {"width": 32, "top": 1617, "height": 17, "left": 436}, "words": "品并"}, {"probability": {"variance": 4.9e-05, "average": 0.996762, "min": 0.973563}, "location": {"width": 200, "top": 1624, "height": 19, "left": 538}, "words": "罕见报告本品治疗的患者出现"}, {"probability": {"variance": 0.006676, "average": 0.961398, "min": 0.778722}, "location": {"width": 88, "top": 1614, "height": 19, "left": 782}, "words": "品。由于许多"}, {"probability": {"variance": 0.008898, "average": 0.961016, "min": 0.729962}, "location": {"width": 99, "top": 1637, "height": 18, "left": 234}, "words": "进行适当的治疗"}, {"probability": {"variance": 0.011132, "average": 0.943533, "min": 0.605666}, "location": {"width": 227, "top": 1644, "height": 19, "left": 515}, "words": "3枢神经系统脱髓鞘病变(参见“不"}, {"probability": {"variance": 0.00296, "average": 0.972807, "min": 0.79998}, "location": {"width": 224, "top": 1634, "height": 22, "left": 792}, "words": "乳汁分泌,因此哺乳期妇女需考虑"}, {"probability": {"variance": 0, "average": 0.999731, "min": 0.999254}, "location": {"width": 69, "top": 1658, "height": 20, "left": 232}, "words": "免疫抑制"}, {"probability": {"variance": 0.002028, "average": 0.979427, "min": 0.814758}, "location": {"width": 233, "top": 1665, "height": 21, "left": 505}, "words": "良反应”)。另外,有十分罕见的外"}, {"probability": {"variance": 0.021478, "average": 0.952494, "min": 0.489087}, "location": {"width": 160, "top": 1655, "height": 20, "left": 782}, "words": "是否停止喃乳或停用本品"}, {"probability": {"variance": 0.000114, "average": 0.991312, "min": 0.962353}, "location": {"width": 173, "top": 1685, "height": 17, "left": 265}, "words": "由于肿瘤坏死因子(TNF"}, {"probability": {"variance": 0.044833, "average": 0.857281, "min": 0.383866}, "location": {"width": 183, "top": 1704, "height": 19, "left": 266}, "words": "炎症反应并调节细胞免疫"}, {"probability": {"variance": 0.000389, "average": 0.989527, "min": 0.939575}, "location": {"width": 345, "top": 1680, "height": 36, "left": 509}, "words": "周脱髓鞘性多发性神经病的报告儿童用药"}], "language": 3}